---
title: "INNVENTURE INC C/WTS 02/10/2029 (TO PUR COM) | 8-K: FY2025 Q3 Revenue: USD 534 K"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/265799757.md"
datetime: "2025-11-13T22:16:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/265799757.md)
  - [en](https://longbridge.com/en/news/265799757.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/265799757.md)
generator: "portal-rs"
---

# INNVENTURE INC C/WTS 02/10/2029 (TO PUR COM) | 8-K: FY2025 Q3 Revenue: USD 534 K

Revenue: As of FY2025 Q3, the actual value is USD 534 K.

EPS: As of FY2025 Q3, the actual value is USD -0.51.

EBIT: As of FY2025 Q3, the actual value is USD -32.61 M.

### Segment Revenue

-   Revenue for the three months ended September 30, 2025: $534 thousand
-   Revenue for the nine months ended September 30, 2025: $1,234 thousand

### Operational Metrics

-   Net loss for the three months ended September 30, 2025: - $34,735 thousand
-   Net loss for the nine months ended September 30, 2025: - $429,684 thousand
-   Operating costs for the three months ended September 30, 2025: $29,739 thousand
-   Operating costs for the nine months ended September 30, 2025: $434,211 thousand

### Cash Flow

-   Net cash used in operating activities for the nine months ended September 30, 2025: - $56,328 thousand
-   Net cash used in investing activities for the nine months ended September 30, 2025: - $4,079 thousand
-   Net cash provided by financing activities for the nine months ended September 30, 2025: $63,349 thousand

### Unique Metrics

-   Adjusted EBITDA for the three months ended September 30, 2025: - $17,464 thousand
-   Adjusted EBITDA for the nine months ended September 30, 2025: - $55,466 thousand

### Outlook / Guidance

-   Innventure is poised to deliver meaningful revenue growth in the quarters and years ahead.

### Related Stocks

- [INVLW.US](https://longbridge.com/en/quote/INVLW.US.md)

## Related News & Research

- [Inside Coca-Cola’s secretive innovation labs: How the beverage giant wants to automate dirty soda and refreshers](https://longbridge.com/en/news/296681725.md)
- [Powerful Growth, Multiple Endorsements Bode Well for Oracle Stock](https://longbridge.com/en/news/296686709.md)
- [Fractyl Health Earnings Call Signals Promise Amid Risks](https://longbridge.com/en/news/296690642.md)
- [Korea Investment CORP Increases Stock Position in L3Harris Technologies Inc $LHX](https://longbridge.com/en/news/296698330.md)
- [Johnson & Johnson $JNJ Position Reduced by Oppenheimer Asset Management Inc.](https://longbridge.com/en/news/296697035.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**